Overview: Discusses new candidate for rapid-acting antidepressants.Provides information for those who work in the field of CNS drugs.Ideal for pharmacologists, psychiatrists, and those who want to learn about CThis book discusses new candidates for rapid-acting antidepressants, such as (R)-ketamine, (2R,6R)-hydroxynorketamine, scopolamine, mGluR2/3 antagonists and AMPA receptor agonists. There are serious limitations to currently available antidepressants, such as delayed onset and low rates of efficacy. The discovery that a single dose of ketamine, an NMDAR antagonist, can produce rapid an
|